Comprehensive Knee Osteoarthritis Index (CKOAI): Scale Development, Validation and Reliability Testing
CKOAI
3 other identifiers
interventional
52
1 country
1
Brief Summary
Background: Symptoms, balance, mobility, activities of daily life (ADL) and quality of life (QoL) are to be considered in rehabilitation of the individuals with knee osteoarthritis (IKOA). There are several scales to evaluate subjective perceptions and individual components in patients with osteoarthritis (OA). Till date, no scale is available to measure the combined balance, mobility, ADL and QoL in PKOA. Objectives: The objectives of the study are to develop a combined measure of symptoms, balance, mobility, ADL and QoL in PKOA, as comprehensive knee osteoarthritis index (CKOAI) and to validate the scale for its content, reliability and minimum detectable change (MDC) Methods: The study consists of a three stages. First stage is the scale (CKOI) item development and validation. This includes domain and item generating through systematic literature search to extract items related symptoms, balance, mobility, ADL and QoL in IKOA based on the International Classification of Functioning, Disability and Health (ICF) and through structured interviews. During scale validation, an expert panel will review the generated domains and items by Delphi Method, which will undergo revision and pilot testing. Based on the responsiveness of pilot testing will be revised finally. Second stage is to test re-test reliability. The third stage is to report the standard error of measurement (SEM) and minimal detectable change (MDC). Data analysis: All the domains and items in CKOAI will undergo reliability and criterion-related validity. Minimum 50 IKOA will be evaluated with the scale on two occasions within two weeks to establish test retest reliability. Cronbach's alpha for internal consistency and Intra class correlation coefficient for test retest reliability will be used to determine the degree of consistency of items in the scale. MDC will be calculated using the formulae, SEM = SD x √ (1-reliability) and MDC95 = √2 x (1.9) x (SEM). Significant level will be set at p value less than 0.05 (p \< 0.05) to minimize the type-I error.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 5, 2018
CompletedFirst Posted
Study publicly available on registry
April 17, 2018
CompletedStudy Start
First participant enrolled
April 17, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 12, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 13, 2019
CompletedMarch 7, 2019
March 1, 2019
10 months
April 5, 2018
March 5, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Comprehensive Knee Osteoarthritis Index
Set of patient reported outcome measures
two occasions within two weeks to establish test retest reliability
Study Arms (1)
Test-retest reliability testing
OTHERMinimum 50 IKOA will be evaluated with the scale on two occasions within two weeks to establish test retest reliability.
Interventions
Set of patient reported outcome measures
Eligibility Criteria
You may qualify if:
- Individuals with osteoarthritic changes of grade 1 and greater on knee radiograph (Kellgren and Lawrence)
- Individuals with unilateral or bilateral knee osteoarthritis
- Both male and female
- Individuals who able to understand simple command
- Individuals who are willing to participate
You may not qualify if:
- History of hip and knee replacement surgery
- History of knee arthroscopic surgery within 6 months
- Any neurologic and musculoskeletal condition which affect their movement or balance
- Comorbidities such as cancer or cardiovascular disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maharishi Markandeshwar Institute of physiotherapy and Rehabilitation
Ambāla, Haryana, 133207, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Kanimozhi D Narkeesh, PhD
Maharishi Markandeshwar Institute of physiotherapy and Rehabilitation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor and Research Scholar
Study Record Dates
First Submitted
April 5, 2018
First Posted
April 17, 2018
Study Start
April 17, 2018
Primary Completion
February 12, 2019
Study Completion
February 13, 2019
Last Updated
March 7, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared with other researchers. We are planned to publish the results in journal.